| Bioactivity | Acetyl-(D-Phe2,Lys15,Arg16,Leu27)-VIP (1-7)-GRF (8-27), a vasoactive intestinal peptide (VIP), is a VIP1 antagonist[1]. |
| Name | Acetyl-(D-Phe2,Lys15,Arg16,Leu27)-VIP (1-7)-GRF (8-27) |
| CAS | 202463-00-1 |
| Sequence | Ac-His-{d-Phe}-Asp-Ala-Val-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Lys-Arg-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-NH2 |
| Shortening | Ac-H-{d-Phe}-DAVFTNSYRKVLKRLSARKLLQDIL-NH2 |
| Formula | C150H246N44O38 |
| Molar Mass | 3273.83 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. M G Juarranz, et al. Vasoactive intestinal polypeptide VPAC1 and VPAC2 receptor chimeras identify domains responsible for the specificity of ligand binding and activation. Eur J Biochem. 1999 Oct 1;265(1):449-56. |
Acetyl-(D-Phe2,Lys15,Arg16,Leu27)-VIP (1-7)-GRF (8-27)
CAS: 202463-00-1 F: C150H246N44O38 W: 3273.83
Acetyl-(D-Phe2,Lys15,Arg16,Leu27)-VIP (1-7)-GRF (8-27), a vasoactive intestinal peptide (VIP), is a VIP1 antagonist.
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.